Friday recap for the XRP Army ⚔️ Alright XRP Army, let’s get into this week’s rundown. Big moves. Big setbacks. Plenty to unpack. Hold the line! 👇 • The CLARITY Act failed to advance in the Senate, falling short of the 60 votes needed to move forward. • Seven Democratic Senators said the setback was “not the end,” reaffirming their commitment to bipartisan crypto market structure legislation. • The SEC launched its Innovation Exemption, opening a path for limited onchain trading of tokenized U.S. stocks. • RippleX expanded the XRPL AI Starter Kit with support for Stripe and Tempo’s Machine Payments Protocol, bringing AI-agent payments to XRPL. • @Ripple partnered with @GoCards, bringing permanent XRP branding to Denny Crum Court and Louisville Basketball. • XRPL 3.4.0 went live, introducing LendingProtocolV1_1 and expanding native lending and vault infrastructure. • Ripple joined Visa Ventures, Circle Ventures and others in backing Velocity’s expansion of institutional stablecoin infrastructure. • @ClearpoolFin is expanding institutional credit infrastructure toward XRPL, with ethereum:0x8292bb45bf1ee4d140127049757c2e0ff06317ed lending and native credit primitives in the roadmap. • U.S. XRP ETFs reached roughly $1.7B in cumulative net inflows after nine consecutive positive weeks. • Ripple Custody 1.41 shipped with stronger address validation, adding another upgrade to Ripple’s institutional custody stack. Washington hit pause. The ecosystem didn’t. The rails keep moving. $XRP ⚔️ $ARMY
$ARMYShare

Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.
